Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Lung Neoplasms 12Head and Neck Neoplasms 10Rectal Neoplasms 8Prostatic Neoplasms 7Mouth Neoplasms 5Glioblastoma 5Esophageal Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Ovarian Neoplasms 3Neuroblastoma 3Neoplasms 3Laryngeal Neoplasms 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Turcot syndrome 2Tongue Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2

Interventions

Oxaliplatin 166Capecitabine 112Fluorouracil 95Docetaxel 85Cisplatin 84S 1 (combination) 83Leucovorin 64Paclitaxel 58Irinotecan 56pembrolizumab 36sintilimab 34Trastuzumab 34apatinib 30Bevacizumab 21Surgical Procedures, Operative 19Radiotherapy 19titanium silicide 17camrelizumab 17Nivolumab 17Ramucirumab 16Drug Therapy 15Hyperthermic Intraperitoneal Chemotherapy 14Folfox protocol 14Epirubicin 14tislelizumab 13Neoadjuvant Therapy 12Cetuximab 12XELOX 10Tegafur 10Carboplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Stomach Neoplasms × Celecoxib × Clear all
NCT00256321 2019-02-08

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

University of California, Irvine

Phase 2 Terminated
4 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡